✦ LIBER ✦

Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer

✍ Scribed by Ritsu Yamamoto; Masanori Kaneuchi; Masashi Nishiya; Yukiharu Todo; Mahito Takeda; Kazuhira Okamoto; Hiroaki Negishi; Noriaki Sakuragi; Seiichiro Fujimoto; Takeshi Hirano

Publisher: Springer
Year: 2002
Tongue: English
Weight: 95 KB
Volume: 50
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-002-0471-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic and pharmacodynamic anal

Pharmacokinetic and pharmacodynamic analysis of combined chemotherapy with carboplatin and paclitaxel for patients with ovarian cancer

✍ A. Arakawa; H. Nishikawa; K. Suzumori; N. Kato 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 126 KB

A pilot study of docetaxel-carboplatin v

A pilot study of docetaxel-carboplatin versus paclitaxel-carboplatin in Japanese patients with epithelial ovarian cancer

✍ Taisuke Mori; Kenichi Hosokawa; Yoshiyuki Kinoshita; Ai Watanabe; Takeshi Yamagu 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 271 KB

Sorafenib in combination with carboplati

Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer

✍ Martin Pölcher; Meike Eckhardt; Christoph Coch; Matthias Wolfgarten; Kirsten Küb 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 203 KB

Clinical and pharmacokinetic study of TN

Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors

✍ Hai T. Tran; George R. Blumenschein; Charles Lu; Christina A. Meyers; Vali Papad 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 198 KB

Phase I combination trial of gemcitabine

Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy

✍ Keith T. Flaherty; James P. Stevenson; Stephen M. Hahn; Maryann Redlinger; Peter 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 178 KB

A phase 1 and pharmacodynamic study of d

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer

✍ Fang Fang; Curt Balch; Jeanne Schilder; Timothy Breen; Shu Zhang; Changyu Shen; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 2 views

## Abstract ## BACKGROUND: Aberrant DNA methylation is a hallmark of cancer, and DNA methyltransferase inhibitors have demonstrated clinical efficacy in hematologic malignancies. On the basis of preclinical studies indicating that hypomethylating agents can reverse platinum resistance in ovarian c